文献速递胃肠外科围术期管理与 ERAS

直肠癌微创手术演变:美国国家癌症数据库更新

Evolution of minimally invasive surgery for rectal cancer: update from the national cancer database.
PubMed 文献 · Surg Endosc · 2020-02-28

该研究基于2010-2015年美国国家癌症数据库(NCDB),对35809例接受低位前切除术(LAR)的直肠腺癌患者进行倾向匹配分析,比较开放LAR(OLAR)与微创LAR(MI-LAR)的结局。结果显示MI-LAR与更低的环周切缘阳性率、更低的90天全因死亡率、更短的住院时间和更好的长期总生存相关,但30天再入院率更高。

要点

  • MI-LAR与更低的环周切缘阳性率和远端切缘阳性率相关。
  • MI-LAR与更低的90天全因死亡率和更好的长期总生存相关。
  • MI-LAR缩短住院时间但增加30天再入院率。

核心结论

  • MI-LAR与环周切缘清除改善和长期生存改善相关。
  • 在具有高级腹腔镜技能的 experienced 外科医生手中,MI-LAR似乎是安全有效的直肠癌治疗技术。

研究设计与样本

  • 回顾性队列研究,查询2010-2015年NCDB参与者数据使用文件。
  • 纳入接受择期开放LAR(OLAR)或微创LAR(MI-LAR)的直肠腺癌患者。
  • 基于人口学、合并症和肿瘤特征进行1:1倾向匹配。
  • 共识别35809例接受LAR的患者,其中18265例(51.0%)接受MI-LAR。
  • 对高容量学术中心进行亚组分析。

主要发现

  • 倾向匹配后,MI-LAR组环周切缘阳性率5.5% vs. 6.6%(p=0.0094)。
  • MI-LAR组远端切缘阳性率3.6% vs. 4.6%(p=0.0022)。
  • MI-LAR组90天全因死亡率2.0% vs. 2.6%(p=0.0238)。
  • MI-LAR组住院时间5天 vs. 6天(p<0.0001),30天再入院率7.6% vs. 6.5%(p=0.0054)。
  • MI-LAR组长期总生存79% vs. 76%(p<0.0001);Cox模型显示死亡风险降低(HR 0.859,95%CI 0.788-0.937)。

临床怎么用

  • 在经验丰富、具备高级腹腔镜技能的外科医生手中,MI-LAR可作为直肠癌的安全有效选择。
  • 需关注MI-LAR后30天再入院风险较高的情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the use of minimally invasive techniques in colorectal surgery has become increasingly prevalent, concerns remain about the oncologic effectiveness and long-term outcomes of minimally invasive low anterior resection (MI-LAR) for the treatment of rectal cancer. STUDY DESIGN: The 2010-2015 National Cancer Database (NCDB) Participant Data Use File was queried for patients undergoing elective open LAR (OLAR) or MI-LAR for rectal adenocarcinoma. A 1:1 propensity match was performed on the basis of demographics, comorbidity, and tumor characteristics. Outcomes were compared between groups and Cox proportional hazard modeling was performed to identify independent predictors of mortality. A subset analysis was performed on high-volume academic centers. RESULTS: 35,809 patients undergoing LAR were identified of whom 18,265 (51.0%) underwent MI-LAR. After propensity matching, patients receiving MI-LAR were less likely to have a positive circumferential radial margin (CRM) (5.5% vs. 6.6%, p = 0.0094) or a positive distal margin (3.6% vs. 4.6%, p = 0.0022) and had decreased 90-day all-cause mortality (2.0% vs. 2.6%, p = 0.0238). MI-LAR resulted in decreased hospital length of stay (5 vs. 6 days, p < 0.0001) but a greater rate of 30-day readmission (7.6% vs. 6.5%, p = 0.0054). Long-term overall survival was improved with MI-LAR (79% vs. 76%, p < 0.0001). Cox proportional hazard modeling demonstrated a decreased risk of mortality with MI-LAR (HR 0.859, 95% CI 0.788-0.937). CONCLUSION: MI-LAR is associated with improvement in CRM clearance and long-term survival. In the hands of experienced surgeons with advanced laparoscopy skills, MI-LAR appears safe and effective technique for the management of rectal cancer.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Gilmore B, Adam MA, Rhodin K, et al. Evolution of minimally invasive surgery for rectal cancer: update from the national cancer database. Surg Endosc. 2020. PMID: 32112255. doi:10.1007/s00464-020-07393-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。